Kirkland, WA, United States of America

Dina Sologub

This inventor holds 4 USPTO granted patents. Top assignee: Koronis Pharmaceuticals, Inc.. Active years: 2007-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dina Sologub. Retrieved from https://idiyas.com/inventor/dina-sologub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dina Sologub: Innovator in Pharmaceutical Chemistry

Introduction

Dina Sologub is a prominent inventor based in Kirkland, WA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrugs for therapeutic applications. With a total of 4 patents to her name, Sologub is recognized for her innovative approaches to drug design.

Latest Patents

Among her latest patents, Sologub has developed hydrophobic prodrugs of bases, nucleosides, and nucleotides. These inventions provide methods for using the prodrugs as antiviral and anti-cancer chemotherapeutic agents. Her work in this area demonstrates her commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Dina Sologub is currently associated with Koronis Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise in drug formulation and development has positioned her as a key player in the industry.

Collaborations

Throughout her career, Sologub has collaborated with notable colleagues, including Richard Daifuku and Alexander A Gall. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Dina Sologub's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving healthcare. Her work on prodrugs highlights the potential for new therapeutic strategies in combating diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…